Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Changes in Circulatory I-FABP in Elderly Persons in Daily Life

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02831400
Recruitment Status : Completed
First Posted : July 13, 2016
Last Update Posted : June 8, 2017
Sponsor:
Information provided by (Responsible Party):
Suzanne Stokmans, University Medical Center Groningen

Brief Summary:
The purpose of this study is to detect changes in circulatory I-FABP values (50% increase) in elderly volunteers following the combination of moderate physical activity and a standard meal.

Condition or disease Intervention/treatment Phase
Malnutrition Intestinal Integrity Intestinal Fatty Acid Binding Protein (IFABP) Behavioral: Walking test Behavioral: Standard Meal Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 34 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Changes in Circulatory I-FABP in Elderly Persons in Daily Life: A Pilot Study
Actual Study Start Date : July 2016
Actual Primary Completion Date : December 2016
Actual Study Completion Date : June 2017

Arm Intervention/treatment
Experimental: IFABP assessment (1 study group)
30 elderly volunteers
Behavioral: Walking test
Walking test to increase cardiac output, maximum 12 minutes

Behavioral: Standard Meal
After the walking test, volunteers eat a standard warm meal




Primary Outcome Measures :
  1. 50% increase of I-FABP in plasma. [ Time Frame: 2 hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   75 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Age 75 years or older (both sexes)
  2. Participating in the Embrace project.

Exclusion Criteria:

  1. Previous gastrointestinal resections
  2. Chronic inflammatory gastrointestinal disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02831400


Sponsors and Collaborators
University Medical Center Groningen
Investigators
Layout table for investigator information
Principal Investigator: BL van Leeuwen, MD, PhD University Medical Center Groningen
Principal Investigator: JJ de Haan, MD, PhD University Medical Center Groningen

Layout table for additonal information
Responsible Party: Suzanne Stokmans, MD, PhD candidate, University Medical Center Groningen
ClinicalTrials.gov Identifier: NCT02831400    
Other Study ID Numbers: NL54574.042.16
First Posted: July 13, 2016    Key Record Dates
Last Update Posted: June 8, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Malnutrition
Nutrition Disorders